中文 | English
Return
Total: 275 , 1/28
Show Home Prev Next End page: GO
Author:( Xiaoliang ZHANG)

1.Expert consensus on the management of radiopharmaceuticals in medical institutions

Lu XIANG ; Long QIU ; Mingru ZHANG ; Shuai JIANG ; Wanyi CHEN ; Xiaoliang CHEN

China Pharmacy 2026;37(16):2073-2083

2.Significance of precise classification of sacral meningeal cysts by multiple dimensions radiographic reconstruction MRI in guiding operative strategy and rehabilitation.

Jianjun SUN ; Qianquan MA ; Xiaoliang YIN ; Chenlong YANG ; Jia ZHANG ; Suhua CHEN ; Chao WU ; Jingcheng XIE ; Yunfeng HAN ; Guozhong LIN ; Yu SI ; Jun YANG ; Haibo WU ; Qiang ZHAO

Journal of Peking University(Health Sciences) 2025;57(2):303-308

3.Research on the Correlation between Adverse Event Reporting Barriers in Medical Quality(Safety)and Patient Safety Culture

Yang CUI ; Xiaoliang ZHANG ; Jiang WU ; Xue ZHANG

Chinese Hospital Management 2025;45(4):61-65

4.Functional analysis of a nitrate-induced GARP transcription factor AhNIGT1.2 in peanut nodulation.

Xiaoliang LI ; Haitong HE ; Suqin HE ; Luyao WANG ; Wei ZHANG ; Zhaosheng KONG ; Lixiang WANG

Chinese Journal of Biotechnology 2025;41(2):657-669

5.Efficacy of phacoemulsification with intraocular lens implantation combined with limbal relaxing incision in treatment of cataract patients with corneal astigmatism

Guangping GAO ; Xiaoliang ZHANG ; Rui ZHANG ; Yanzhi SANG

Academic Journal of Naval Medical University 2025;46(4):545-549

6.Military cross-cutting symptom scale and its reliability and validity

Xiaoliang WEI ; Tao ZHANG ; Kaitian SHI ; Yi ZHANG ; Yonghai BAI ; Taosheng LIU

Academic Journal of Naval Medical University 2025;46(6):817-823

7.Diagnostic value of serum CCL3 and Semaphorin 3A in patients with T2DM complicated by osteoporosis

Xiaoliang CUI ; Zhihua DUN ; Chen ZHANG ; Tao LIU

International Journal of Laboratory Medicine 2025;46(14):1730-1735

8.A Single-Arm Phase II Clinical Trial of Fulvestrant Combined with Neoadjuvant Chemotherapy of ER+/HER2– Locally Advanced Breast Cancer: Integrated Analysis of 18F-FES PET-CT and Metabolites with Treatment Response

Qing SHAO ; Ningning ZHANG ; Xianjun PAN ; Wenqi ZHOU ; Yali WANG ; Xiaoliang CHEN ; Jing WU ; Xiaohua ZENG

Cancer Research and Treatment 2025;57(1):126-139

9.A Single-Arm Phase II Clinical Trial of Fulvestrant Combined with Neoadjuvant Chemotherapy of ER+/HER2– Locally Advanced Breast Cancer: Integrated Analysis of 18F-FES PET-CT and Metabolites with Treatment Response

Qing SHAO ; Ningning ZHANG ; Xianjun PAN ; Wenqi ZHOU ; Yali WANG ; Xiaoliang CHEN ; Jing WU ; Xiaohua ZENG

Cancer Research and Treatment 2025;57(1):126-139

10.Mechanisms and research progress of circular RNAs in radon exposure-induced diseases

Jia ZHANG ; Xiaoliang LI ; Jianlei RUAN ; Jianxiang LIU

Chinese Journal of Radiological Health 2025;34(2):303-308

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 275 , 1/28 Show Home Prev Next End page: GO